Risperdal Antipsychotic Medication
Introduced in 1994 by the Johnson & Johnson subsidiary Janssen, Risperdal is a second generation antipsychotic medication used to treat schizophrenia, bipolar disorder, and autism in both adults and children. It has also been prescribed off-label to hundreds of thousands of children for the treatment of ADHD.
Unfortunately, recent research has linked the medication to a slew of severe side effects, including abnormal breast development, lactation, and juvenile diabetes. This has been known to occur in boys, young girls, and adult men taking the medication.
Records indicate that the manufacturer knew of these risks but did not properly warn patients, choosing to hide this information in the precaution notes of the product, rather than printing on the medication's general warning label.